$4.92
2.67% today
Nasdaq, Oct 22, 05:47 pm CET
ISIN
US15117N5032
Symbol
IMNN

Celsion Corporation Stock price

$5.06
-0.10 1.84% 1M
-6.53 56.38% 6M
-7.34 59.21% YTD
-7.89 60.95% 1Y
-14.77 74.50% 3Y
-110.18 95.61% 5Y
-4,952.77 99.90% 10Y
-55,462.34 99.99% 20Y
Nasdaq, Closing price Tue, Oct 21 2025
+0.04 0.70%
ISIN
US15117N5032
Symbol
IMNN
Industry

Key metrics

Basic
Market capitalization
$12.7m
Enterprise Value
$8.0m
Net debt
positive
Cash
$4.7m
Shares outstanding
2.0m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
- | -
EV/Sales
- | -
EV/FCF
negative
P/B
4.8
Financial Health
Equity Ratio
43.7%
Return on Equity
-447.7%
ROCE
-461.7%
ROIC
-
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$0.0 | $0.0
EBITDA
$-15.1m | -
EBIT
$-16.0m | $-24.0m
Net Income
$-15.8m | $-21.4m
Free Cash Flow
$-15.0m
Growth (TTM | estimate)
Revenue
- | -
EBITDA
23.1% | -
EBIT
19.5% | -26.2%
Net Income
12.9% | -12.6%
Free Cash Flow
19.2%
Margin (TTM | estimate)
Gross
-
EBITDA
- | -
EBIT
-
Net
- | -
Free Cash Flow
-
More
EPS
$-10.7
FCF per Share
$-7.6
Short interest
8.7%
Employees
25
Rev per Employee
$0.0
Show more

Is Celsion Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,015 stocks worldwide.

Celsion Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a Celsion Corporation forecast:

7x Buy
78%
2x Hold
22%

Analyst Opinions

9 Analysts have issued a Celsion Corporation forecast:

Buy
78%
Hold
22%

Financial data from Celsion Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
- -
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 7.10 7.10
14% 14%
-
- Research and Development Expense 8.92 8.92
23% 23%
-
-15 -15
23% 23%
-
- Depreciation and Amortization 0.94 0.94
236% 236%
-
EBIT (Operating Income) EBIT -16 -16
19% 19%
-
Net Profit -16 -16
13% 13%
-

In millions USD.

Don't miss a Thing! We will send you all news about Celsion Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Celsion Corporation Stock News

Neutral
GlobeNewsWire
2 days ago
Investor event to provide update on pivotal Phase 3 study of IMNN-001 to be held in New York City on November 10, 2025 Program will feature presentations from ovarian cancer thought leaders, Phase 3 study investigators, oncology and statistical experts LAWRENCEVILLE, N.J., Oct. 20, 2025 (GLOBE NEWSWIRE) -- IMUNON , Inc. (Nasdaq: IMNN), a clinical-stage company in Phase 3 development with its DN...
Neutral
GlobeNewsWire
5 days ago
Company seeks strategic partners to advance novel PlaCCine technology LAWRENCEVILLE, N.J., Oct. 17, 2025 (GLOBE NEWSWIRE) -- IMUNON , Inc. (Nasdaq: IMNN), a clinical-stage company focused on developing non-viral DNA-mediated immunotherapies and evaluating an adaptation of the platform's potential as a next-generation vaccine, today announced that members of its leadership team will deliver oral...
Neutral
GlobeNewsWire
8 days ago
Prestigious European Society for Medical Oncology Conference “trials-in-progress” session Pivotal OVATION 3 trial of its DNA-mediated immunotherapy in newly diagnosed patients underway Company on track with established plans to accelerate patient recruitment LAWRENCEVILLE, N.J., Oct. 14, 2025 (GLOBE NEWSWIRE) -- IMUNON , Inc. (Nasdaq: IMNN), a clinical-stage company in Phase 3 development with ...
More Celsion Corporation News

Company Profile

Celsion Corp . is a clinical stage oncology drug company. It focuses on cancer treatments, including directed chemotherapies, DNA-mediated immunotherapy and RNA-based therapies. The firm engages in the research and development of pharmaceutical products for cancer treatments. Its portfolio includes deoxyribonucleic acid-mediated immunotherapy and ribonucleic acid-based therapies. It operates through the Celsion and ThermoDox brands. The company was founded by Yim-Pan Cheung in 1982 and is headquartered in Lawrenceville, NJ.

Head office United States
CEO Stacy Lindborg
Employees 25
Founded 1982
Website imunon.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today